Snail, Inc. (SNAL): Nasdaq/NYSE listing notice — Snail receives Nasdaq delisting notice for failure to meet minimum bid price

Snail, Inc.

Closing bid price was below $1.00 for 30 consecutive business days from Nov 11 to Dec 29, 2025.
Company has 180 calendar days, until June 29, 2026, to regain compliance.
Compliance can be achieved by maintaining $1.00 or higher for at least 10 consecutive business days.
If not compliant by June 29, 2026, company may request 180-day extension subject to conditions.
Company is considering options including a reverse stock split to cure the deficiency.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Snail, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

December 30, 2025, Snail, Inc. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for thirty (30) consecutive business days from November 11, 2025 through December 29, 2025, the Company’s common stock did not maintain a minimum closing bid price of $1.00 per share (the “Minimum Bid Price Requirement”) as required by Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on the listing or trading of the Company’s common stock and the common stock will continue to trade on The Nasdaq

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Snail, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-000108

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.